EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Viral reactivation following COVID-19 vaccination: a review of the current literature

Fabrizio Martora iD, Matteo Megna, Teresa Battista iD, Massimiliano Scalvenzi, Alessia Villani iD, Sara Cacciapuoti, Luca Potestio iD

Clinical and Experimental Dermatology · 2024

DOI: 10.1093/ced/llae061 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Fabrizio Martora und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Napoli, Italy. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Virus Activation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, four vaccines for COVID-19 have been licensed by the European Medicines Agency: two viral vector-based vaccines and two mRNA-based vaccines. Since their approval, several cutaneous reactions related to vaccination have been reported in the literature. Among these, viral reactivations are one of the most frequent. The aim of this article was to investigate the current literature regarding viral reactivations following COVID-19 vaccination, focusing attention on pityriasis rosea (PR), herpes zoster and herpes simplex. A comprehensive literature search using various databases was performed and we included metanalyses, reviews, letters to the editor, real-life studies, case series and reports. A total of 48 articles involving 2067 patients were selected. Of these, 32, 6 and 17 articles reported varicella zoster virus (VZV) reactivation (1758 patients), herpes simplex virus (HSV) (238 patients) onset and PR (71 patients), respectively (some articles discussed more than one of these three reactivations). Possible pathogenetic mechanisms underlying viral reactivation are still not understood. Also, the possible correlations between vaccination and viral reactivation should be clarified. Certainly, vaccination should not be discouraged.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesVirus ActivationHumansCOVID-19Herpes SimplexHerpes ZosterHerpesvirus 3, HumanSimplexvirusVaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Napoli, Italy.

ORCID-Profile: Fabrizio Martora, Teresa Battista, Alessia Villani, Luca Potestio

Zitieren

APA

Martora, F., Megna, M., Battista, T., Scalvenzi, M., Villani, A., Cacciapuoti, S., & Potestio, L. (2024). Viral reactivation following COVID-19 vaccination: a review of the current literature. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae061

Vancouver

Martora F, Megna M, Battista T, Scalvenzi M, Villani A, Cacciapuoti S, et al. Viral reactivation following COVID-19 vaccination: a review of the current literature. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae061

BibTeX
@article{Martora2024,
  author = {Martora, Fabrizio and Megna, Matteo and Battista, Teresa and Scalvenzi, Massimiliano and Villani, Alessia and Cacciapuoti, Sara and Potestio, Luca},
  title = {Viral reactivation following COVID-19 vaccination: a review of the current literature},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  doi = {10.1093/ced/llae061}
}
Kostenlos starten →